Skip to main content
Back to General Catalyst

General Catalyst's Biotechnology Portfolio

Browse 10 Biotechnology companies funded by General Catalyst. See funding amounts, founder contacts, and investment details.

Biotechnology Companies
10
Total Funding in Biotechnology
$453.5M

Biotechnology Portfolio Companies (10)

Export
BiotechnologyHealth CareOncologyTherapeutics

Odyssey Therapeutics creates precision immunomodulators and oncology medicines for patients with cancer and inflammatory diseases.

Boston, United States
May 2026
$213.0M
Post-IPO Equity

Founder Contacts

19,000+ verified contacts

BiopharmaBiotechnologyMedicalTherapeutics

ParcelBio develops biotechnology focused on RNA medicine delivery systems and therapeutic development platforms.

San Francisco, United States
May 2026
$13.2M
Seed

Founder Contacts

19,000+ verified contacts

BiotechnologyComputer VisionMachine Learning

Optimizing cell therapy with spatial biology

New York, United States
May 2026
$14.5M
Series A

Founder Contacts

19,000+ verified contacts

BiotechnologyLife ScienceOncologyPharmaceutical

ArriVent develops pharmaceutical products to cure presently untreatable cancer.

Pennsylvania Furnace, United States
May 2026
Post-IPO Equity

Founder Contacts

19,000+ verified contacts

BiotechnologyHealth CareMedicalService IndustryTherapeutics

Rakuten Medical is a biotechnology company developing investigational cancer therapies based on its proprietary Alluminox platform.

San Diego, United States
April 2026
$100.0M
Venture - Series Unknown

Founder Contacts

19,000+ verified contacts

BiopharmaBiotechnologyGeneticsTherapeutics

Maze Therapeutics is a biotechnology company that develops precision medicines for renal, cardiovascular, and metabolic diseases.

South San Francisco, United States
April 2026
Post-IPO Equity

Founder Contacts

19,000+ verified contacts

BiotechnologyHealth CareLife ScienceMedical Device

Ossium Health builds a bone marrow bank to treat blood cancers.

San Francisco, United States
April 2026
Venture - Series Unknown

Founder Contacts

19,000+ verified contacts

BiotechnologyHealth CareLife ScienceMedicalTherapeutics

Dewpoint Therapeutics is a biotech company developing a drug platform that targets biomolecular condensates.

Boston, United States
September 2025
$59.1M
Series D

Founder Contacts

19,000+ verified contacts

Artificial Intelligence (AI)BiotechnologyTherapeutics

Tahoe Therapeutics is a biotechnology company that develops AI models of human cells to enhance drug discovery.

South San Francisco, United States
August 2025
$30.0M
Venture - Series Unknown

Founder Contacts

19,000+ verified contacts

BiotechnologyHealth CareHealth Diagnostics

Mirvie is a biotech company that creates precise, actionable, and non-invasive tests for maternal-fetal health.

South San Francisco, United States
August 2025
$23.7M
Venture - Series Unknown

Founder Contacts

19,000+ verified contacts

Explore General Catalyst's Full Portfolio

View all companies funded by General Catalyst across every industry and funding stage.

View Full General Catalyst Portfolio
General Catalyst Biotechnology Portfolio - 10 Companies | VCBacked